·Confidence 90%
Shuttle Pharmaceuticals Receives Nasdaq Notice for Late Filing
Key takeaways
- Shuttle Pharmaceuticals has received a notice from Nasdaq due to its failure to meet the deadline for filing its 10-Q report, raising concerns for investors.
Analysis
Shuttle Pharmaceuticals has received a notice from Nasdaq due to its failure to meet the deadline for filing its 10-Q report, raising concerns for investors.
0 likes · 0 dislikes